Unit of Excellence in Immunotoxicology, Finnish Institute of Occupational Health, Helsinki, Finland.
J Invest Dermatol. 2010 Feb;130(2):342-4. doi: 10.1038/jid.2009.372.
MK2 is a promising candidate for treating inflammation. Mice deficient in MK2 were studied in models of inflammation to see whether MK2 could be a useful target in inflammatory skin disease. Surprisingly, MK2 played only a minor role in skin inflammation, indicating that modulation of cell signaling gives different results depending on the models of inflammation and target organs that are studied.
MK2 是一种很有前途的治疗炎症的候选药物。研究人员在炎症模型中研究了缺乏 MK2 的小鼠,以观察 MK2 是否可以成为炎症性皮肤病的一个有用靶点。令人惊讶的是,MK2 在皮肤炎症中只起次要作用,这表明细胞信号转导的调节会因所研究的炎症模型和靶器官的不同而产生不同的结果。